Cargando…

Comment on “Facial Atrophy in Oral Submucous Fibrosis: An Association or a Coincidence”

Detalles Bibliográficos
Autores principales:	Grover, Sonal, Koshy, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116494/ https://www.ncbi.nlm.nih.gov/pubmed/27891262 http://dx.doi.org/10.1155/2016/5747458

Ejemplares similares

Facial Atrophy in Oral Submucous Fibrosis: An Association or a Coincidence
por: Shetty, Sameep S., et al.
Publicado: (2016)

Medical management of oral submucous fibrosis
por: Shanbhag, Vagish Kumar Laxman
Publicado: (2015)

Oral submucous fibrosis: Are we doing enough?
por: Chugh, Ankita, et al.
Publicado: (2019)

Comment on: Facial nerve palsy after COVID-19 vaccination – A rare association or coincidence
por: Gurnani, Bharat, et al.
Publicado: (2022)

Response to comment on: Facial nerve palsy after COVID-19 vaccination – A rare association or coincidence
por: Ish, Somya, et al.
Publicado: (2022)

Immunohistochemical analysis of syndecan-1 in leukoplakia and oral submucous fibrosis
por: Kamat, Sushant S., et al.
Publicado: (2013)

Oral submucous fibrosis: an update
por: Wollina, Uwe, et al.
Publicado: (2015)

Oral submucous fibrosis: An update
por: Ray, Jay Gopal, et al.
Publicado: (2017)

Epithelial Atrophy, Fibrosis and Vascularity Correlation with Epithelial Dysplasia in Oral Submucous Fibrosis, a Prospective Study
por: Kapoor, Ruchika, et al.
Publicado: (2020)

Epithelial atrophy in oral submucous fibrosis is mediated by copper (II) and arecoline of areca nut
por: Khan, Imran, et al.
Publicado: (2015)

Histopathology of Oral Submucous Fibrosis in Third Dimension with an Additional note on Hypothesis of Epithelial Atrophy
por: Tamgadge, Sandhya, et al.
Publicado: (2019)

Facial nerve palsy after COVID-19 vaccination – A rare association or a coincidence
por: Ish, Somya, et al.
Publicado: (2021)

Lipid profile in oral submucous fibrosis
por: Mehrotra, Ravi, et al.
Publicado: (2009)

Management of Oral Submucous Fibrosis with Injection of Hyaluronidase and Dexamethasone in Grade III Oral Submucous Fibrosis: A Retrospective Study
por: James, Leena, et al.
Publicado: (2015)

Comment on: Childhood optic atrophy in biotinidase deficiency
por: Venugopal, N, et al.
Publicado: (2016)

PTEN and α-SMA Expression and Diagnostic Role in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma with Concomitant Oral Submucous Fibrosis
por: Monteiro, Roshni, et al.
Publicado: (2021)

Submucous fibrosis of the oral cavity. Histomorphological studies.
por: Wahi, P. N., et al.
Publicado: (1966)

Proliferation and apoptosis markers in oral submucous fibrosis
por: Ranganathan, K, et al.
Publicado: (2011)

Oral submucous fibrosis and its dermatological relation
por: Ali, Fareedi Mukram, et al.
Publicado: (2014)

Pathogenesis and therapeutic intervention of oral submucous fibrosis
por: Yoithapprabhunath, Thukanaykanpalayam Ragunathan, et al.
Publicado: (2013)

Immunohistochemical Analysis of Vimentin in Oral Submucous Fibrosis
por: Nayak, Meghanand T., et al.
Publicado: (2013)

Oral submucous fibrosis and plasma lipid profile
por: Pantvaidya, G. H., et al.
Publicado: (2013)

Carcinoma Arising in the Background of Oral Submucous Fibrosis
por: Rangaswamy, Shruthi, et al.
Publicado: (2019)

Evaluation of Hematological Profile in Oral Submucous Fibrosis
por: Abidullah, Mohammed, et al.
Publicado: (2022)

Drug treatment for oral submucous fibrosis: an update
por: Chen, Xueru, et al.
Publicado: (2023)

Scoring criteria for the evaluation of micronuclei in oral exfoliated cells
por: Grover, Sonal, et al.
Publicado: (2017)

Submucous Lipoma of Sigmoid Colon: A Rare Entity
por: Babu, Kinnera Vijay Sreedhar, et al.
Publicado: (2009)

Comparison of Immunohistochemical Markers in Oral Submucous Fibrosis and Oral Submucous Fibrosis Transformed to Oral Squamous Cell Carcinoma—A Systematic Review and Meta-Analysis
por: Mohapatra, Diksha, et al.
Publicado: (2023)

PTMA, a new identified autoantigen for oral submucous fibrosis, regulates oral submucous fibroblast proliferation and extracellular matrix
por: Wang, Jie, et al.
Publicado: (2017)

Prognostic potential of AgNORs in oral submucous fibrosis
por: Murgod, Sanjay, et al.
Publicado: (2016)

Buccal fat pad reconstruction for oral submucous fibrosis
por: Surej, Kumar L. K., et al.
Publicado: (2010)

Ultrasonographic Evaluation of Oral Submucous Fibrosis and Masseteric Hypertrophy
por: Devathambi, Jones Raja, et al.
Publicado: (2013)

Areca nut and its role in oral submucous fibrosis
por: Prabhu, Rachana V., et al.
Publicado: (2014)

Plasma fibrinogen degradation products in oral submucous fibrosis
por: Gupta, Sonia, et al.
Publicado: (2015)

Evaluation of oxidative stress and the microenvironment in oral submucous fibrosis
por: Rai, Vertika, et al.
Publicado: (2019)

Effectiveness of Osteopathic Therapy in the Treatment of Oral Submucous Fibrosis
por: Goyal, Manu, et al.
Publicado: (2017)

Photobiomodulation therapy inhibits oral submucous fibrosis in mice
por: Chiang, Min‐Hsuan, et al.
Publicado: (2020)

Oral submucous fibrosis and COVID-19: Perspective on comorbidity
por: Sarode, Sachin C., et al.
Publicado: (2020)

Research Achievements of Oral Submucous Fibrosis: Progress and Prospect
por: Xu, Hui, et al.
Publicado: (2021)

Determination of Effectiveness of Photobiomodulation in the Treatment of Oral Submucous Fibrosis
por: Sukanya, D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g4n1o5c8kofbdus1p3cb8v60s0